R&D

  • overview
  • Technologies
  • R&D Pipeline
  • Open Innovation
  • Achivement

Achievements Achievements

Samyang Biopharmaceuticals Corp. will develop into a global company with a mission to realize enriched and healthy human life through unceasing efforts and aggressive investments, firmly grounded on present achievements

  • Product Launch
  • Patent Technology
  • Awards and Certificates

Research at Samyang Biopharmaceuticals R&D center focuses on pharmaceuticals and medical devices. On the foundation of previously acquired platform technologies, the center is actively conducting R&D, thus unveiling a variety of products.

The signature products of Samyang Biopharmaceuticals Corp. include cytotoxic anticancer drugs (for lung cancer, ovarian cancer, blood cancer, etc) , pain management patches, smoking cessation adjuvant patches, anti-inflammatory patches, and biodegradable surgical sutures, all of which have been well received by patients and medical staff and highly acclaimed in the global market.

Product Launch Image

The scientists at Samyang Biopharmaceuticals Corp. are experts in their fields with years of research experience in new drug development and drug delivery systems from leading academic and industrial institutions.

The key researchers at Samyang Biopharmaceuticals Corp. have contributed an average of 3.13 papers to the SCI-level international journals, a figure far higher than the average of 0.17 by the researchers in other companies in Korea (Ministry of Education, Science, and Technology, Analysis of Science and Technology Theses,

November 2010). Furthermore, the Biomedical Research Center at Samyang Biopharmaceuticals Corp. currently possesses over 999 registered patents, 711 of which are international patents. Among these, 50 key patents are being used in manufacturing products, thus generating sales. Based on these diverse patents, Samyang Biopharmaceuticals Corp. continues to make unceasing efforts to utilize DDS and to develop enhanced new drugs.

Awards Awards

  • 1992.04
  • Science Day’s Technology R&D
    Silver-Tower Order of Industrial Service Merit
    Institution : Ministry of Science and Technology
    Description : Contribution to the advancement of science and technology
  • 1994.10
  • Patented Technology Award
    Institution : Korean Patent Office
    Description : Manufacture of glycolide
  • 1997.05
  • IR52 Jang Young Shil Award*
    Institution : Maeil Business Newspaper, KOITA
    Description : Bioabsorbable Surgical Suture TRISORB
  • 1999.10
  • IR52 Jang Young Shil Award*
    Institution : Maeil Business Newspaper, KOITA
    Description : Anticancer Drug Paclitaxel ‘Genexol
  • 2000.12
  • Grand Prize (Bioindustry Award) 2000**
    Institution : Korea Bio, The Korea Economic Daily
    Description : Anticancer Drug Paclitaxel ‘Genexol’
  • 2002.03
  • Patented Technology Award Chi-Seok-Young Award
    Institution : Korean Patent Office, Joongang Ilbo
    Description : Patent for Genexol-PM "Insoluble Drug Containing System
    (Patent Registration No. 0289074)“ - Acquisition date: February 14, 2001
  • 2007.02
  • The 8th Korea New Drug Award, Excellence Award
    Institution : KDRA, MEST, Ministry of Health and Welfare, Ministry of Knowledge Economy
    Description : Genexol-PM (Pharmaceutical agent for treating breast cancer and non-small cell lung cancer)
  • 2012.06
  • Certified as an “Innovated Pharmaceutical Company” by the Ministry of Health and Welfare. (1st time)
  • 2015.05
  • Re-certified as an “Innovated Pharmaceutical Company” by the Ministry of Health and Welfare.
  • 2016.10
  • Designated as an Advanced technology center (ATC) by the Ministry of Industrial trade and management.
  • 2018.05
  • Re-certified as an “Innovated Pharmaceutical Company” by the Ministry of Health and Welfare.